Skip to main content

Advertisement

Table 1 Patient characteristics

From: Safety of intravenously applied mistletoe extract – results from a phase I dose escalation study in patients with advanced cancer

Characteristics
Age in years (median and range) 64 (42–74)
Gender (number of male and female patients) 17 / 4
ECOG-performance status (number of patients)
 0 5
 1 12
 2 4
Primary tumour (number of patients)
 Prostate cancer 4
 Colorectal cancer 3
 Renal cell cancer 2
 Hepatocellular cancer 2
 Sarcoma 2
 Glioblastoma 1
 Lung cancer 1
 Stomach cancer 1
 Pancreatic cancer 1
 Gall bladder cancer 1
 Tonsil cancer 1
 Thyroid (C-cell) cancer 1
 Thrombocythemia 1
Previous treatment (number of patients)
 Surgery 15
 Chemotherapy 14
 Radiotherapy 9
 Immunotherapy 4
Time since primary cancer diagnosis (years) 6.7 ± 8.8
Body mass index (kg/m2) 24.2 ± 5.6
Blood pressure (mmHg) 126 ± 18 / 82 ± 11
Puls rate (Beats/min) 72 ± 13
Rectal temperature (°C) 36.6 ± 0.5